Targeted protein degrader development for cancer: advances, challenges, and opportunities
Trends in Pharmacological Sciences · 2023-05 · 44 (5) · 303-317
DOI: 10.1016/j.tips.2023.03.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Trends in Pharmacological Sciences, 2023-05. Verfasst von Yuan Fang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and …. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 109-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Beijing Municipal Health Commission, Chinese Academy of Medical Sciences.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
- Department of Chemistry, BeiGene (Beijing) Co. Ltd, Beijing 100020, China.
- Translational Discovery, Research, and Medicine, BeiGene (Beijing) Co. Ltd, Beijing 100020, China.
- Clinical Trials Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China. Electronic addres…
Förderung
- Beijing Municipal Health Commission
- Chinese Academy of Medical Sciences
Zitieren
APA
Fang, Y., Wang, S., Han, S., Zhao, Y., Yu, C., Liu, H., & Li, N. (2023). Targeted protein degrader development for cancer: advances, challenges, and opportunities. Trends in Pharmacological Sciences, 44(5), 303-317. https://doi.org/10.1016/j.tips.2023.03.003
Vancouver
Fang Y, Wang S, Han S, Zhao Y, Yu C, Liu H, et al. Targeted protein degrader development for cancer: advances, challenges, and opportunities. Trends in Pharmacological Sciences. 2023;44(5):303-317. doi:10.1016/j.tips.2023.03.003
BibTeX
@article{Fang2023,
author = {Fang, Yuan and Wang, Shuhang and Han, Songzhe and Zhao, Yizhou and Yu, Cunjing and Liu, Huaqing and Li, Ning},
title = {Targeted protein degrader development for cancer: advances, challenges, and opportunities},
journal = {Trends in Pharmacological Sciences},
year = {2023},
volume = {44},
number = {5},
pages = {303--317},
doi = {10.1016/j.tips.2023.03.003}
}
EUVIMED